Promising new cervical cancer test fills in the gap missed by Pap tests

Researchers assessed a novel human papillomavirus (HPV) and host deoxyribonucleic acid (DNA) methylation score for adenocarcinoma in-situ (AIS) and cervical adenocarcinoma (ADC) screening.

Skyelarke makes public significant changes to SkyePay – Pharmaceutical Technology

The new changes will make it easier for clinical trials patients to receive payment. Image credit: PopTika via Shutterstock. Skyelarke, the health technology company specialising

July 12, 2023

Lilly exec says developing new therapies for lupus is ‘in scope’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 6, 2024

Novo Nordisk’s oral semaglutide on par with injectable version in weight loss and safety

An oral version of Novo Nordisk’s semaglutide helped patients taking the highest dose lose 15% of their body weight. It’s on par with Novo’s Wegovy,

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.